| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
2 companies
Cohen Chad M serves as a Director at GRND and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 81 sells. Those positions are worth an estimated $1.0M at current prices.
Historically, Cohen Chad M's trades have earned a strong insider score of 87/100 across 19 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +73.4%.
The biggest single holding is ADPT (~$539K) as Chief Financial Officer. The recent filings there lean toward selling, a net 943,375 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 10,000 | $40.24 | $402,425.30 | -18.2% | -8.2% | -68.8% | |
| Jan 29, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 100,000 | $56.13 | $5,612,600.92 | -55.3% | - | - | |
| Jan 26, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 100,000 | $65.05 | $6,505,455.66 | -41.8% | - | - | |
| Jan 20, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 50,000 | $67.33 | $3,366,555.26 | -51.6% | - | - | |
| Jan 19, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 50,000 | $68.61 | $3,430,421.21 | -34.9% | - | - | |
| Jan 13, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 50,000 | $63.41 | $3,170,267.80 | -58.0% | - | - | |
| Jan 12, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 75,000 | $62.59 | $4,694,543.17 | -65.7% | - | - | |
| Dec 8, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 30,000 | $51.24 | $1,537,238.40 | -69.7% | - | - | |
| Nov 9, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 30,000 | $49.16 | $1,474,705.44 | -63.0% | - | - | |
| Oct 8, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 30,000 | $50.65 | $1,519,428.60 | -78.4% | - | - |